FindTrial
Sign In

The effect of propofol smooth target control infusion on hemodynamics and anesthesia depth of induction period in high risk patients

The effect of propofol smooth target control infusion on hemodynamics and anesthesia depth of induction period in obstructive jaundice patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020364
Enrollment
Unknown
Registered
2018-12-25
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive jaundice

Interventions

Group 1:propofol smooth target controlled infusion
Group 2:propofol injection

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: Serum TBL 47.2-389.1µmol/L; age 45-70years; ASA physical status I to III.

Exclusion criteria

Exclusion criteria: Known or suspected cardiac, pulmonary, renal or metabolic disease, weight beyond ±20% of ideal, age older than 70years or younger than 45years, and patients taking any form of analgesic or neuro-modulating medications.

Design outcomes

Primary

MeasureTime frame
MAP;CO;SV;PSI;—

Secondary

MeasureTime frame
burst suppression;Vasoactive drug dosage;—

Countries

China

Contacts

Public ContactGu Erwei

The First Affiliated Hospital of Anhui Medical University

ay_guew_mz@163.com+86 13966663478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026